European guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology

Background The treatment of severe dermatological autoimmune diseases and toxic epidermal necrolysis (TEN) with high-dose intravenous immunoglobulin (IVIg) is a well-established procedure in dermatology. As treatment with IVIg is usually considered for rare clinical entities or severe clinical cases...

Full description

Bibliographic Details

Main Authors:	Enk, Alexander (Author) , Hadaschik, Eva (Author) , Eming, R. (Author) , Fierlbeck, G. (Author) , French, L. E. (Author) , Girolomoni, G. (Author) , Hertl, M. (Author) , Jolles, S. (Author) , Karpati, S. (Author) , Steinbrink, K. (Author) , Stingl, G. (Author) , Volc‐Platzer, B. (Author) , Zillikens, D. (Author)
Format:	Article (Journal)
Language:	English
Published:	13 July 2016
In:	Journal of the European Academy of Dermatology and Venereology Year: 2016, Volume: 30, Issue: 10, Pages: 1657-1669
ISSN:	1468-3083
DOI:	10.1111/jdv.13725
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/jdv.13725 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/jdv.13725
Author Notes:	A.H. Enk, E.N. Hadaschik, R. Eming, G. Fierlbeck, L.E. French, G. Girolomoni, M. Hertl, S. Jolles, S. Karpati, K. Steinbrink, G. Stingl, B. Volc‐Platzer, D. Zillikens